JP2005508289A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508289A5
JP2005508289A5 JP2002591455A JP2002591455A JP2005508289A5 JP 2005508289 A5 JP2005508289 A5 JP 2005508289A5 JP 2002591455 A JP2002591455 A JP 2002591455A JP 2002591455 A JP2002591455 A JP 2002591455A JP 2005508289 A5 JP2005508289 A5 JP 2005508289A5
Authority
JP
Japan
Prior art keywords
phenyl
diethylcarbamoyl
benzamide
piperidin
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002591455A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508289A (ja
Filing date
Publication date
Priority claimed from SE0101769A external-priority patent/SE0101769D0/xx
Application filed filed Critical
Publication of JP2005508289A publication Critical patent/JP2005508289A/ja
Publication of JP2005508289A5 publication Critical patent/JP2005508289A5/ja
Pending legal-status Critical Current

Links

JP2002591455A 2001-05-18 2002-05-16 4−(フェニル−(ピペリジン−4−イル)−アミノ)−ベンズアミド誘導体及び疼痛、不安症又は胃腸障害の治療のためのその使用 Pending JP2005508289A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101769A SE0101769D0 (sv) 2001-05-18 2001-05-18 Novel compounds
PCT/SE2002/000944 WO2002094782A1 (en) 2001-05-18 2002-05-16 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders

Publications (2)

Publication Number Publication Date
JP2005508289A JP2005508289A (ja) 2005-03-31
JP2005508289A5 true JP2005508289A5 (enExample) 2005-12-22

Family

ID=20284172

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002591455A Pending JP2005508289A (ja) 2001-05-18 2002-05-16 4−(フェニル−(ピペリジン−4−イル)−アミノ)−ベンズアミド誘導体及び疼痛、不安症又は胃腸障害の治療のためのその使用

Country Status (26)

Country Link
US (1) US7226933B2 (enExample)
EP (1) EP1395555B1 (enExample)
JP (1) JP2005508289A (enExample)
KR (1) KR20030094425A (enExample)
CN (1) CN1639123A (enExample)
AR (1) AR033758A1 (enExample)
AT (1) ATE313528T1 (enExample)
BG (1) BG108330A (enExample)
BR (1) BR0209670A (enExample)
CA (1) CA2446311A1 (enExample)
CO (1) CO5540317A2 (enExample)
CZ (1) CZ20033089A3 (enExample)
DE (1) DE60208192T2 (enExample)
EE (1) EE200300554A (enExample)
HU (1) HUP0401328A2 (enExample)
IL (1) IL158628A0 (enExample)
IS (1) IS7028A (enExample)
MX (1) MXPA03010440A (enExample)
NO (1) NO20035113D0 (enExample)
NZ (1) NZ529398A (enExample)
PL (1) PL366387A1 (enExample)
RU (1) RU2003131966A (enExample)
SE (1) SE0101769D0 (enExample)
SK (1) SK13912003A3 (enExample)
WO (1) WO2002094782A1 (enExample)
ZA (1) ZA200308631B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2476583C (en) * 2002-03-13 2011-07-05 Kristof Van Emelen Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
SE0300987D0 (sv) * 2003-04-03 2003-04-03 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
KR20140015122A (ko) 2003-10-01 2014-02-06 아돌로 코포레이션 스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) * 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
WO2008033299A2 (en) * 2006-09-12 2008-03-20 Adolor Corporation Use of n-containing spirocompounds for the enhancement of cognitive function
SI3233825T1 (sl) * 2014-12-19 2020-10-30 Pharmnovo Ab Derivati diarilmetiliden-piperidina in njihova uporaba kot agonisti delta opioidnega receptorja
US20250084091A1 (en) * 2021-05-04 2025-03-13 The Texas A&M University System Inhibitors of sars-cov-2

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091096A (en) * 1976-03-19 1978-05-23 Eli Lilly And Company Dinitroanilines for the control of phytopathogens
EG12406A (en) * 1976-08-12 1979-03-31 Janssen Pharmaceutica Nv Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
US4252812A (en) * 1977-05-23 1981-02-24 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
SE441448B (sv) 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
DE3563964D1 (en) * 1984-10-16 1988-09-01 Synthelabo Piperidine derivatives, their preparation and their therapeutical application
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
KR940003491B1 (ko) * 1989-08-10 1994-04-23 리히터 게데온 베기에스제티 기아르 알.티 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물
US5854245A (en) * 1996-06-28 1998-12-29 Merck & Co., Inc. Fibrinogen receptor antagonists
SE9604786D0 (sv) * 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
CA2316341A1 (en) 1997-12-24 1999-07-08 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
JP4498602B2 (ja) 1998-03-10 2010-07-07 リサーチ・トライアングル・インスティチュート 新規なオピエート化合物、その調製法及び使用法
SE9904675D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
US6552036B2 (en) * 2000-03-03 2003-04-22 Ortho-Mcneil Pharmaceutical, Inc. 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
SE0001207D0 (sv) * 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
JPWO2009028275A1 (ja) * 2007-08-28 2010-11-25 コニカミノルタエムジー株式会社 シンチレータパネル

Similar Documents

Publication Publication Date Title
JP2005508293A5 (enExample)
JP2005510457A5 (enExample)
JP2003529596A5 (enExample)
JP2006522035A5 (enExample)
CA2446326A1 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
JP2005505583A5 (enExample)
US7115645B2 (en) 1,2 diarylbenzimidazoles and their pharmaceutical use
JP2014509298A5 (enExample)
EP1680402A1 (fr) Derives de n-[[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
JP2004538285A5 (enExample)
RU2009105398A (ru) Замещенные гетероарильные производные
JP2005508292A5 (enExample)
JP2010526025A5 (enExample)
AU782993B2 (en) 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
JP2005508858A5 (enExample)
JP2005508290A5 (enExample)
JP2005507372A5 (enExample)
RU2324680C2 (ru) Производные диарилметилиденпиперидина, их применение, способы и промежуточное соединение для их получения
JP2005510456A5 (enExample)
JP2003529598A5 (enExample)
RU2326875C2 (ru) Производные 4-(фенил-пиперазинил-метил)бензамида и их применение для лечения боли или желудочно-кишечных расстройств
JP2006508946A5 (enExample)
RU2003131966A (ru) Производные 4-(фенил-(пиперидин-4-ил)-амино)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств
RU2007127864A (ru) Производные n-[(4, 5-дифенил-3-алкил-2-тиенил)метил]амина (амид, сульфонамид, карбамат и карбамид) в качестве антагонистов рецепторов св1 каннабиноидов
US20060142296A1 (en) 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders